Craft

Novoprotein

Stock Price

¥35.3

2024-10-29

Market Capitalization

¥2.4 B

2024-10-29

Revenue

¥126 M

FY, 2024

Novoprotein Summary

Company Summary

Overview
Novoprotein (also known as 诺唯赞) is a biotechnology company that develops and supplies recombinant proteins, reagents, and contract research and manufacturing services for biopharmaceutical and research purposes. It provides recombinant proteins including cytokines, target proteins, growth factors, biosimilar reference antibodies, and virus-related products, as well as reagents for molecular and immunodiagnostics. The company offers protein expression and purification, virus-like particle production, antibody discovery and engineering, cell line development, custom production of in vitro transcribed mRNA, circular RNA, and self-amplifying RNA, and process development and manufacturing for biologics and nucleic acid therapeutics. It serves the research reagent, contract research, and contract manufacturing markets for biologics and advanced therapies.
Type
Public
Status
Active
Founded
2009
HQ
Suzhou, CN | view all locations
Website
https://novoprotein.com
Cybersecurity rating
Sectors

Key People

  • Zhu Huaxing

    Zhu Huaxing, Founder, Chairman

    • Wang Yingming

      Wang Yingming, Deputy Managing Director

      • Wang Duqiang

        Wang Duqiang, Deputy Managing Director. Board Secretary

        • Zhao Yujian

          Zhao Yujian, Deputy Managing Director

          LocationsView all

          9 locations detected

          • Suzhou, Jiang Su Sheng HQ

            China

            Floor 4, No. 228, Yunchuang Road, Wujiang District

          • Summit, NJ

            United States

            THE LINCOLN BUILDING, 86 Summit Ave

          • Beijing, Bei Jing Shi

            China

            5-1906, Brilliant International, Shangdi 10th Street, Haidian District

          • Chengdu, Si Chuan Sheng

            China

            Room 1003, Building 2, Haide International Plaza, No. 2, Keyuan South Road, Wuhou District

          • Guangzhou, Guang Dong Sheng

            China

            813, 8/F, Building 3, VTRON Innovation Park, 233 Kezhu Road, Huangpu District

          • Hangzhou, Zhe Jiang Sheng

            China

            Room 1009, 10/F, No. 183, Wenhui Road, Gongshu District

          and 3 others

          Novoprotein Financials

          Summary Financials

          Revenue (Q3, 2025)
          ¥40.5M
          Gross profit (Q3, 2025)
          ¥25.5M
          Net income (Q3, 2025)
          (¥4.6M)
          Cash (Q3, 2025)
          ¥799.2M
          EBIT (Q3, 2025)
          (¥16.1M)
          Enterprise value
          $1.7B

          Footer menu